-->

Tag: Adjuvant Therapy

Home / Adjuvant Therapy

Categories

Neoadjuvant and adjuvant pembrolizumab is approved by the USFDA for resectable locally advanced head and neck squamous cell carcinoma

On June 12, 2025, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for adults with advanced head and neck squamous cell carcinoma (HNSCC) that can be surgically removed and sh...
adjuvant-therapy

Kisqali with an aromatase inhibitor and Kisqali Femara Co-Pack is approved by the USFDA for early high-risk breast cancer

On September 17, 2024, the Food and Drug Administration approved ribociclib (Kisqali, Novartis Pharmaceuticals Corporation) in conjunction with an aromatase inhibitor for the adjuvant therapy of adult...
adjuvant-therapy

Scan the code